Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis

Numerous studies have demonstrated that the expression level of maternally expressed gene 3 (MEG3) was lost in various cancers. Low expression of MEG3 is associated with an increased risk of metastasis and a poor prognosis in cancer patients. This meta-analysis investigated the association between M...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Xiangrong, Jing, Xuan, Long, Chunlan, Tian, Jie, Zhu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386668/
https://www.ncbi.nlm.nih.gov/pubmed/28157702
http://dx.doi.org/10.18632/oncotarget.14987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386668/
https://www.ncbi.nlm.nih.gov/pubmed/28157702
http://dx.doi.org/10.18632/oncotarget.14987

Ejemplares similares